Mode
Text Size
Log in / Sign up

TEAS at PC6 during hepatectomy does not reduce PONV incidence within 24 hoursSurgery Nausea: Why a Common Pain Relief Method May Not Help After All

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that TEAS at PC6 did not reduce PONV after hepatectomy; analgesic-sparing effects are uncertain.

In a multi-center, double-blind randomized controlled trial conducted at three tertiary hospitals in China, 161 patients scheduled for elective hepatectomy were assigned to intraoperative transcutaneous electrical acupoint stimulation (TEAS) at PC6 or no stimulation. All patients received standard antiemetic therapy. The primary outcome was the incidence of postoperative nausea and vomiting (PONV) within 24 hours postoperatively.

The primary outcome did not differ between groups: 23.8% in the TEAS group versus 26.6% in the control group (OR 0.86, 95% CI 0.42–1.76). For secondary outcomes, the TEAS group had fewer patient-controlled analgesia (PCA) attempts (2.7 vs 3.5) and fewer PCA deliveries (2.6 vs 3.5); p-values were not reported. There was no difference between groups in time to ambulation or time to gastrointestinal function recovery.

Safety and tolerability were not reported. Key limitations include the absence of reported p-values for secondary outcomes and the lack of reported adverse events. The practice relevance is that intraoperative TEAS did not significantly reduce PONV incidence in hepatectomy patients receiving antiemetic therapy; any potential to decrease analgesic requirements warrants further investigation.

Here is the article based on your specifications.

Surgery Nausea: Why a Common Pain Relief Method May Not Help After All

A large, multi-center study tested a popular non-drug approach during major liver surgery. The goal was to reduce nausea and vomiting. The results challenge what many doctors and patients hoped would be true.

Postoperative nausea and vomiting (PONV) is one of the most uncomfortable parts of recovering from surgery. It affects about 1 in 3 patients. For someone undergoing a hepatectomy—a major surgery to remove part of the liver—feeling sick can make a tough recovery even harder.

Doctors usually give anti-sickness drugs to help. But researchers wanted to see if adding a non-drug technique could work even better.

The technique is called TEAS. It stands for transcutaneous electrical acupoint stimulation. It uses small electrical pulses on the skin to stimulate specific points on the body. It is similar to acupuncture but non-invasive.

The surprising shift

For years, studies have suggested that stimulating certain body points can help with pain and nausea. It is a common practice in some parts of the world, especially China, where this study took place.

The hope was simple: adding TEAS to standard drug therapy would lower the number of patients who felt sick after surgery.

But here’s the twist. In this specific high-stakes surgery, it didn't work as expected for nausea.

To understand this study, you have to understand PONV. Think of your stomach and brain connected by a complex highway of nerves.

When you have surgery, the anesthesia drugs and the physical stress of the operation act like roadblocks on that highway. This causes traffic to back up. That "traffic" is the feeling of nausea.

The standard drugs act like traffic cops, directing cars to slow down. TEAS is thought to work by calming the nerves at specific "exit ramps" on the body (the acupoints). The idea is that if you calm the nerves, the brain gets fewer "sick" signals.

Researchers tested this by placing electrodes on the PC6 point. This is a spot on the inner wrist. It is a well-known spot for motion sickness.

The study snapshot

Researchers ran a double-blinded trial across three major hospitals in China. "Double-blinded" means neither the patient nor the doctor knew if the machine was truly on. This prevents bias.

They enrolled 161 patients scheduled for elective hepatectomy. Half got real TEAS stimulation during surgery. The other half got a "sham" version where the machine was on but didn't deliver the therapeutic current. Everyone got the standard two anti-nausea drugs.

They tracked who got sick within 24 hours of waking up.

The numbers were clear, though perhaps disappointing for fans of the technique.

About 24% of patients in the TEAS group felt nauseous. In the control group, it was about 27%. Statistically, this difference was not significant. It means the result could have been due to chance.

In plain English: Adding the electrical stimulation didn't lower the odds of feeling sick compared to just taking the medicine.

However, there was a silver lining.

The TEAS group needed less pain medication. They pressed their pain relief buttons fewer times. They also received fewer doses of the painkiller itself.

But there’s a catch

This is where things get interesting. While the nausea results were a "no-go," the pain relief results were promising.

Why didn't the study shout about this pain relief? Because reducing pain wasn't the main goal of the study. When researchers look for one thing and find another, they have to be careful not to overstate it.

This doesn’t mean TEAS is useless for surgery recovery.

The researchers concluded that while TEAS didn't reduce nausea in this specific group of patients, the potential to reduce pain medication is worth exploring.

In surgery, using fewer opioids (strong painkillers) is a major goal. Fewer drugs mean fewer side effects like constipation, itching, or drowsiness. It also helps patients get back on their feet faster.

If you or a loved one is facing liver surgery, this study suggests that TEAS might not be the magic bullet for nausea that we hoped for. Relying on proven anti-nausea medications remains the standard of care.

However, if you are interested in non-drug pain management, this is an area to watch. It suggests TEAS might play a role in keeping pain under control, potentially reducing the need for pills.

This study had some strict rules. It only looked at patients having liver surgery. The results might be different for other types of surgery.

Also, the study compared TEAS to a "sham" treatment. Both groups received standard drugs. It is possible that the standard drugs were so effective that they masked any small benefit TEAS might have provided.

The researchers suggest that more studies are needed. Future studies might test different electrical settings or different timing.

For now, TEAS remains a tool that shows mixed results. It didn't stop the nausea, but it might help with the pain. Science is often about finding out what doesn't work so we can focus on what does.

Study Details

Study typeRct
EvidenceLevel 2
PublishedDec 2026
View Original Abstract ↓
INTRODUCTION: This study evaluated whether adding transcutaneous electrical acupoint stimulation (TEAS) to a double-antiemetic regimen during hepatectomy reduces the incidence of postoperative nausea and vomiting (PONV). METHODS: In this multicenter double-blinded randomized controlled trial conducted across three tertiary hospitals in China, patients scheduled for elective hepatectomy were randomized to either the TEAS group (stimulation at PC6 during surgery) or the control group (no stimulation). The primary outcome was the incidence of PONV within 24 h postoperatively. Key secondary outcomes included the severity of PONV and pain after surgery. RESULTS: Among 161 randomized patients, 159 completed the study. No significant difference was observed in the incidence of PONV within 24 h postoperatively between the TEAS and control groups (23.8% vs. 26.6%; OR, 95% CI: 0.86, 0.42-1.76). However, the TEAS group exhibited less patient controlled analgesia (PCA) attempts (2.7 vs 3.5) or deliveries (2.6 vs 3.5) by 24 h postoperatively. Recovery outcomes, including time to ambulation and to gastrointestinal function recovery, did not differ between groups. CONCLUSION: Intraoperative TEAS did not significantly reduce PONV incidence in hepatectomy patients receiving antiemetic therapy. Nonetheless, its potential to decrease the need for analgesics warrants further investigation to refine its role in perioperative care. CLINICAL TRIAL REGISTRATION: ClinicalTrial.gov (NCT05396716), https://clinicaltrials.gov.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.